NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

translocations or amplifications on top of the genomic alterations currently current in the original CLL, but lack the common mutations noticed in primary DLBCL indicating which they might correspond to a special Organic group.Therapy for relapsed/refractory ailment must be determined determined by prior therapy and likewise The main reason why the